Latest Insider Transactions at Kiora Pharmaceuticals Inc (KPRX)
This section provides a real-time view of insider transactions for Kiora Pharmaceuticals Inc (KPRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of KIORA PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of KIORA PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 02
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-0.76%
|
$540
$3.7 P/Share
|
|
Jun 04
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
155
-0.99%
|
$620
$4.19 P/Share
|
|
Jun 04
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
155
-0.98%
|
$620
$4.19 P/Share
|
|
Jun 04
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-0.76%
|
$720
$4.19 P/Share
|
|
Jun 04
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
878
-1.24%
|
$3,512
$4.19 P/Share
|
|
May 04
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
191
-1.2%
|
$764
$4.13 P/Share
|
|
May 04
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
158
-0.99%
|
$632
$4.13 P/Share
|
|
May 04
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
177
-0.74%
|
$708
$4.13 P/Share
|
|
May 04
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
889
-1.24%
|
$3,556
$4.13 P/Share
|
|
Apr 08
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-1.19%
|
$768
$4.94 P/Share
|
|
Apr 08
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-1.2%
|
$776
$4.94 P/Share
|
|
Apr 08
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-0.75%
|
$720
$4.94 P/Share
|
|
Apr 08
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
899
-1.23%
|
$3,596
$4.94 P/Share
|
|
Mar 03
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-1.18%
|
$960
$5.46 P/Share
|
|
Mar 03
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-1.18%
|
$960
$5.46 P/Share
|
|
Mar 03
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
218
-0.9%
|
$1,090
$5.46 P/Share
|
|
Mar 03
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
898
-1.22%
|
$4,490
$5.46 P/Share
|
|
Feb 02
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,282
-5.01%
|
$7,692
$6.34 P/Share
|
|
Feb 02
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
3,542
-4.58%
|
$21,252
$6.34 P/Share
|
|
Feb 02
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
988
-5.73%
|
$5,928
$6.34 P/Share
|
|
Feb 02
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
990
-5.73%
|
$5,940
$6.34 P/Share
|
|
Jan 06
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jan 06
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,531,101
+31.39%
|
$7,655,505
$5.22 P/Share
|
|
Jan 04
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-0.66%
|
$460
$4.85 P/Share
|
|
Jan 04
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-0.66%
|
$460
$4.85 P/Share
|
|
Jan 04
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-0.45%
|
$460
$4.85 P/Share
|
|
Jan 04
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
705
-0.9%
|
$2,820
$4.85 P/Share
|
|
Dec 07
2020
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-0.35%
|
$273
$3.76 P/Share
|
|
Dec 07
2020
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-0.52%
|
$273
$3.76 P/Share
|
|
Dec 07
2020
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
588
-0.75%
|
$1,764
$3.76 P/Share
|
|
Dec 07
2020
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-0.52%
|
$273
$3.76 P/Share
|
|
Nov 02
2020
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
97
-0.55%
|
$291
$3.51 P/Share
|
|
Nov 02
2020
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
97
-0.37%
|
$291
$3.51 P/Share
|
|
Nov 02
2020
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
96
-0.55%
|
$288
$3.51 P/Share
|
|
Nov 02
2020
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
623
-0.79%
|
$1,869
$3.51 P/Share
|
|
Oct 02
2020
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
98
-0.56%
|
$294
$3.88 P/Share
|
|
Oct 02
2020
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
98
-0.38%
|
$294
$3.88 P/Share
|
|
Oct 02
2020
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
98
-0.55%
|
$294
$3.88 P/Share
|
|
Oct 02
2020
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
631
-0.79%
|
$1,893
$3.88 P/Share
|
|
Feb 10
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Feb 10
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
12,000
+0.66%
|
$72,000
$6.04 P/Share
|
|
Feb 06
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Feb 06
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
11,000
+0.61%
|
$66,000
$6.18 P/Share
|
|
Sep 30
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 30
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
5,001
+0.14%
|
$15,003
$3.14 P/Share
|
|
Sep 29
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 29
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
600,000
+25.13%
|
$1,800,000
$3.12 P/Share
|
|
Mar 29
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Mar 29
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
298,189
+1.65%
|
$0
$0.31 P/Share
|
|
Mar 28
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|